Skip to Content
 
Center for International Blood and Marrow Transplant Research

Summary Slides & Reports

Main Content

CIBMTR data on outcomes and trends are summarized and made available for clinical decision-making, presentations, and research planning.

The US Summary Slides - Trends and Survival Data

Using information from our outcomes database, CIBMTR annually prepares and distributes charts summarizing current uses and outcomes of cellular therapies in a set of US Summary Slides.
 

The US Summary Slides

The US Summary Slides are an annual report on data submitted to CIBMTR by centers in the US and describes information related to practices and general survival outcomes after cellular therapies. The current edition includes procedures performed prior to 2024.

  • The US Summary Slides 2024 (PowerPoint) - Updated April 2025 
    • To cite the US Summary Slides
      • Citation: Spellman SR, Xu K, Oloyede T, Ahn KW, Akhtar O, Bolon YT, Broglie L, Bloomquist J, Bupp C, Chen M, Devine SM, El-Jurdi N, Hamadani M, Hengen M, Huppler AH, Jaglowski S, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Perez W, Phelan R, Rizzo D, Saber W, Stefanski HE, Steinert P, Tuschl E, Visotcky A, Vogel R, Auletta JJ, Shaw BE, Allbee-Johnson M. Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR. Transplant Cell Ther. 2025 Aug;31(8):505-532. doi: 10.1016/j.jtct.2025.05.014. Epub 2025 May 19. PMID: 40398621; PMCID: PMC12302970.

    • Slides 3 to 49 exhibit data on frequency of transplants according to transplant and CAR–T infusion type, donor, patient age, graft source, graft-versus-host disease (GVHD)prophylaxis, disease, causes of death, conditioning regimen, and race and/or ethnicity. All frequencies represent first autologous and allogeneic transplants and CAR-T infusions registered with the CIBMTR during the period.

    • Slides 50 to 69 include overall survival outcomes according to age, donor type, disease, disease status, year of infusion, and race and ethnicity. Comparisons across survival curves are univariate and do not adjust for all potentially important factors; consequently, results should be interpreted cautiously.  

  • 2020-2023 PRO Summary Slides (PowerPoint)
  • Slides are also available upon request by contacting info-request@mcw.edu.
     

Previous Year's HCT Summary Slides

Previous Year's Adoptive Cellular Therapy Summary Slides

Summary of the current use, outcomes, trends of adoptive cellular therapies in the United States

US Transplant and Survival Statistics on Related Sites

In addition to the data and resources available through this website, hematopoietic cell transplantation (HCT) data collected and analyzed by CIBMTR are also available through related websites.

In this section:
C.W. Bill Young Cell Transplantation Program website
NMDP website

C.W. Bill Young Cell Transplantation Program website

Autologous, Related and Unrelated Allogeneic Transplant Data

In 2006, CIBMTR was awarded a contract from the Health Resources and Services Administration of the US Department of Health and Human Services to administer the Stem Cell Therapeutic Outcomes Database (SCTOD) of the C.W. Bill Young Cell Transplantation Program.

As a part of this contract, CIBMTR provides statistics about autologous, related, and unrelated allogeneic transplants performed by US transplant centers:

  • US Patient Survival Report
    View patient survival estimates for a disease and the length of time after transplant: 100 days, 1 year, and 3 years. You can also select survival estimates by patient age, patient gender, patient race, or cell source.
  • HRSA Transplant Activity Report, Dataset, and Data Dictionary
    View tables reflecting the number of bone marrow and cord blood transplants performed at transplant centers in the US, by patient age, patient gender, patient race, cell source, the year when the transplant was performed, disease, donor type, and the state in which the transplant center is located. You can also download the dataset supporting these tables to create additional views. 

NMDP website

Allogeneic Transplant Data, by Transplant Center

CIBMTR performs a center-specific survival analysis each year as part of the C.W. Bill Young Cell Transplantation Program. The methodology for this analysis (click to view the previous methodology) is reviewed at the Center Outcomes Forum every other year. The results of this analysis are incorporated into a comprehensive guide of all US transplant centers that perform allogeneic transplants (using related or unrelated donors). The listing includes the kinds of transplants performed, transplant outcomes, diseases treated, and general cost information for each center.

  • US Transplant Center Listing
    Each transplant center listing includes information about facilities, personnel, diseases treated, cost, and transplant experience, including the number of transplants performed and survival rates by age, disease type, and disease stage.

 

Publication Permission Request

Use the form below to request permission to reproduce CIBMTR slides or data. Your request will receive prompt attention.

Publication Permission Request Form

Please note that a permission request is subject to the following conditions:

  • If used publicly, the following statement must be included: “The views expressed in this article are that of the authors and does not reflect the position of the Center for International Blood and Marrow Transplant Research.”

  • Appropriate credit for CIBMTR data is required.

  • Except as herein provided, no adaptation of changes shall be made to CIBMTR's materials without prior written consent of CIBMTR.

  • CIBMTR material shall be used only in the manner as described above. If CIBMTR material is sought for inclusion in a new edition or updated version to a document or publication from which copyright permission is currently being sought, a new CIBMTR Copyright Permission Request Form must be submitted to CIBMTR.